Get started
Clene Inc.Clene Inc.Clene Inc.

Clene Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

CLNN chart

Key stats

Market capitalization
‪42.56 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.5450USD
Net income
‪−49.50 M‬USD
Revenue
‪654.00 K‬USD
Shares float
‪67.95 M‬
Beta (1Y)
2.07

About Clene Inc.

Sector
Health Technology
CEO
Robert Dee Etherington
Headquarters
Salt Lake City
Website
clene.com
Employees (FY)
85
Founded
2013
ISIN
US1856341029
FIGI
BBG00X3GTK66
Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CLNN is 0.33 USD — it has decreased by 7.87% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Clene Inc. stocks are traded under the ticker CLNN.
Clene Inc. is going to release the next earnings report on May 6, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Clene Inc. has a max estimate of 7.00 USD and a min estimate of 1.00 USD.
CLNN earnings for the last quarter are −0.02 USD whereas the estimation was −0.09 USD which accounts for 77.78% surprise. Estimated earnings for the next quarter are −0.07 USD. See more details about Clene Inc. earnings.
Clene Inc. revenue for the last quarter amounts to ‪108.00 K‬ USD despite the estimated figure of ‪136.00 K‬ USD. In the next quarter revenue is expected to reach ‪145.00 K‬ USD.
Yes, you can track Clene Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, CLNN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Clene Inc. stock right from TradingView charts — choose your broker and connect to your account.
CLNN reached its all-time high on Jul 13, 2021 with the price of 17.82 USD, and its all-time low was 0.25 USD and was reached on Dec 27, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 85.00 employees. See our rating of the largest employees — is Clene Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Clene Inc. EBITDA is ‪−38.52 M‬ USD, and current EBITDA margin is ‪−5.94 K‬%. See more stats in Clene Inc. financial statements.